AAAAAA
Results:
1-20
|
Results: 20
Authors:
Kageyama, S
Yamamoto, H
Nakazawa, H
Yoshimoto, R
Citation: S. Kageyama et al., Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs, THROMB RES, 101(5), 2001, pp. 395-404
Authors:
Murata, T
Yamawaki, H
Yoshimoto, R
Hori, M
Sato, K
Ozaki, H
Karaki, H
Citation: T. Murata et al., Chronic effect of doxorubicin on vascular endothelium assessed by organ culture study, LIFE SCI, 69(22), 2001, pp. 2685-2695
Authors:
Takahara, A
Hirasawa, A
Dohmoto, H
Shoji, M
Yoshimoto, R
Sugiyama, A
Hashimoto, K
Citation: A. Takahara et al., In vivo antiarrhythmic profile of AP-792 assessed in different canine arrhythmia models, JPN J PHARM, 87(1), 2001, pp. 21-26
Authors:
Takahara, A
Dohmoto, H
Yoshimoto, R
Sugiyama, A
Hashimoto, K
Citation: A. Takahara et al., Utilization of telemetry system to assess the cardiovascular profile of AH-1058, a mew cardioselective Ca2+ channel blocker, in conscious dogs, JPN J PHARM, 85(3), 2001, pp. 331-334
Authors:
Takahara, A
Dohmoto, H
Yoshimoto, R
Sugiyama, A
Hashimoto, K
Citation: A. Takahara et al., Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry, EUR J PHARM, 413(1), 2001, pp. 101-108
Authors:
Konda, T
Takahara, A
Maeda, K
Dohmoto, H
Yoshimoto, R
Citation: T. Konda et al., Effects of a dual L/N-type Ca2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs, EUR J PHARM, 413(1), 2001, pp. 117-120
Authors:
Kageyama, S
Yamamoto, H
Yoshimoto, R
Citation: S. Kageyama et al., Anti-human von willebrand factor monoclonal antibody AJvW3 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs, ART THROM V, 20(10), 2000, pp. 2303-2308
Authors:
Gong, HB
Rashid, M
Nakamura, T
Hattori, K
Nakazawa, M
Kihara, H
Yoshimoto, R
Nagatomo, T
Citation: Hb. Gong et al., Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig coronary arteries induced by 5-HT and alpha-methylserotonin: Comparison with ketanserin, BIOL PHAR B, 23(9), 2000, pp. 1105-1107
Authors:
Takahara, A
Sugiyama, A
Dohmoto, H
Yoshimoto, R
Hashimoto, K
Citation: A. Takahara et al., Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations, J CARDIO PH, 35(5), 2000, pp. 741-748
Authors:
Kihara, H
Hirose, K
Koganei, H
Sasaki, N
Yamamoto, H
Kimura, A
Nishimori, T
Shoji, M
Yoshimoto, R
Citation: H. Kihara et al., AT-1015, a novel serotonin (5-HT)(2) receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats, J CARDIO PH, 35(4), 2000, pp. 523-530
Authors:
Yoshimoto, R
Hori, M
Ozaki, H
Karaki, H
Citation: R. Yoshimoto et al., Proteolysis of acidic calponin by mu-calpain, J BIOCHEM, 128(6), 2000, pp. 1045-1049
Authors:
Yoshimoto, R
Hori, M
Takahashi, K
Taniguchi, S
Katsuki, M
Ozaki, H
Karaki, H
Citation: R. Yoshimoto et al., Ca2+-sensitization of contraction in the h1 calponin-deficient smooth muscle, JPN J PHARM, 84(4), 2000, pp. 474-475
Authors:
Takahara, A
Sugiyama, A
Dohmoto, H
Yoshimoto, R
Hashimoto, K
Citation: A. Takahara et al., Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model, JPN J PHARM, 83(2), 2000, pp. 107-112
Authors:
Takahara, A
Sugiyama, A
Dohmoto, H
Yoshimoto, R
Hashimoto, K
Citation: A. Takahara et al., Antiarrhythmic and cardiohemodynamic effects of a novel Ca2+ channel blocker, AH-1058, assessed in canine arrhythmia models, EUR J PHARM, 398(1), 2000, pp. 107-112
Authors:
Takahashi, K
Yoshimoto, R
Fuchibe, K
Fujishige, A
Mitsu-Saito, M
Hori, M
Ozaki, H
Yamamura, H
Awata, N
Taniguchi, S
Katsuki, M
Tsuchiya, T
Karaki, H
Citation: K. Takahashi et al., Regulation of shortening velocity by calponin in intact contracting smoothmuscles, BIOC BIOP R, 279(1), 2000, pp. 150-157
Authors:
Uneyama, H
Takahara, A
Wakamori, M
Mori, Y
Yoshimoto, R
Citation: H. Uneyama et al., Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review), INT J MOL M, 3(5), 1999, pp. 455-466
Authors:
Eto, K
Isshiki, T
Yamamoto, H
Takeshita, S
Ochiai, M
Yokoyama, N
Yoshimoto, R
Ikeda, Y
Sato, T
Citation: K. Eto et al., AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes, ART THROM V, 19(4), 1999, pp. 877-882
Authors:
Takahara, A
Uneyama, H
Sasaki, N
Ueda, H
Dohmoto, H
Shoji, M
Hara, Y
Nakaya, H
Yoshimoto, R
Citation: A. Takahara et al., Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmiasand cardiac membrane currents, J CARDIO PH, 33(4), 1999, pp. 625-632
Authors:
Uneyama, H
Uchida, H
Konda, T
Yoshimoto, R
Akaike, N
Citation: H. Uneyama et al., Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels, EUR J PHARM, 373(1), 1999, pp. 93-100
Authors:
Uneyama, H
Uchida, H
Maeda, K
Yoshimoto, R
Watanabe, Y
Inoue, K
Citation: H. Uneyama et al., Non-L-type actions of organic Ca2+ channel blockers: Implications for Na+ and N-type Ca2+ channels blockades, CALCIUM ION MODULATORS, 1998, pp. 13-23
Risultati:
1-20
|